Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
EpiCept Corporation to Present at the 5th Annual Noble Financial Equity Conference TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT)...
-
EpiCept Releases New Data Demonstrating Long-Term Durability of Ceplene in Sustaining Leukemia-Free Survival Data to Be Presented at the European Hematology Association's 14th Congress TARRYTOWN,...
-
EpiCept Partners With IDIS For Ceplene® Named Patient/Compassionate Use Program Partnership Expands Access to Drug in Most Key Markets TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation...
-
EpiCept Announces Webcast of Annual Meeting of Stockholders TARRYTOWN,N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced that its annual meeting of...
-
EpiCept Announces Presentation of New Crinobulin Data at 2009 American Society of Clinical Oncology Annual Meeting TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX...
-
EpiCept Corporation Reports First Quarter 2009 Operating and Financial Results TARRYTOWN, N.Y.--(BUSINESS WIRE)--EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced operating...
-
EpiCept to Report First Quarter 2009 Operating and Financial Results on May 7, 2009 TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today announced...
-
Notice of the Annual Meeting of Stockholders of EpiCept Corporation TARRYTOWN, N.Y.--(BUSINESS WIRE)--Regulatory News: With this notice, stockholders of EpiCept Corporation (Nasdaq and OMX...
-
EpiCept Appoints Recognized Oncology Expert and Pharmaceutical Industry Leader as New Independent Board Member TARRYTOWN, N.Y.--(BUSINESS WIRE)-- Regulatory News: EpiCept Corporation (Nasdaq and...
-
EpiCept Corporation Reports Fourth Quarter and Full Year 2008 Operating and Financial Results TARRYTOWN, N.Y.--(BUSINESS WIRE)-- EpiCept Corporation (Nasdaq and OMX Nordic Exchange: EPCT) today...